Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Herberg

Ali Alejo Herberg, Madrid ES

Patent application numberDescriptionPublished
20090104178Chemokine binding activity of viral tnf receptors and related proteins - Chemokine binding activity of viral TNF receptors and related proteins. The invention relates to a C-terminal domain (CTD) of viral tumour necrosis factor receptors (vTNFRs) CrmB or CrmD or CTD homologues (CTD1, CTD2 and CTD3) from poxvirus and their functional homologues, including derivatives, and fragments, for use in binding chemokines and their analogues and/or to enhance the immunomodulatory properties of TNFRs or in bloking binding of chemokines to their corresponding cell surface receptors and/or to modulate chemokine biological activity.04-23-2009

Ben W. Herberg, Andover, MN US

Patent application numberDescriptionPublished
20110106217CONTROLLING EFFECTS CAUSED BY EXPOSURE OF AN IMPLANTABLE MEDICAL DEVICE TO A DISRUPTIVE ENERGY FIELD - Techniques are described for controlling effects caused when an implantable medical device (IMD) is subject to a disruptive energy field. The IMD may include an implantable lead that includes one or more electrodes. The IMD may further include a first component having a parasitic inductance. The IMD may further include a second component having a reactance. In some examples, the reactance of the second component may be selected based on the parasitic inductance of the first component such that an amount of energy reflected along the lead in response to energy produced by an electromagnetic energy source is below a selected threshold. In additional examples, the parasitic inductance of the first component and the reactance of the second component are configured such that an amount of energy reflected along the lead in response to a frequency of electromagnetic energy is below a selected threshold.05-05-2011
20110106218CONTROLLING EFFECTS CAUSED BY EXPOSURE OF AN IMPLANTABLE MEDICAL DEVICE TO A DISRUPTIVE ENERGY FIELD - Techniques are described for controlling effects caused when an implantable medical device (IMD) is subject to a disruptive energy field. The IMD may include an implantable lead that includes one or more electrodes. The IMD may further include a first component having a parasitic inductance. The IMD may further include a second component having a reactance. In some examples, the reactance of the second component may be selected based on the parasitic inductance of the first component such that an amount of energy reflected along the lead in response to energy produced by an electromagnetic energy source is below a selected threshold. In additional examples, the parasitic inductance of the first component and the reactance of the second component are configured such that an amount of energy reflected along the lead in response to a frequency of electromagnetic energy is below a selected threshold.05-05-2011
20110118813ELECTRODE ASSEMBLY IN A MEDICAL ELECTRICAL LEAD - A medical device lead is presented that includes an electrode assembly having a first electrode located near a distal end of the electrode assembly and a second electrode located near a proximal end of the electrode assembly. The electrode assembly also includes a conductive elongated coupler that is electrically coupled to the first electrode and capacitively coupled to the second electrode. At low frequencies and DC (e.g., during delivery of stimulation therapy), the capacitive coupling between the conductive elongated coupler and the second electrode presents a high impedance allowing little current to be redirected from the first electrode to the second electrode. However, at high frequencies (e.g., during an MRI scan) the capacitive coupling between the conductive elongated coupler and the second electrode presents a low impedance, resulting in a significant amount of induced current being redirected to the second electrode and dissipated into bodily fluid surrounding the second electrode.05-19-2011

Duane Herberg, Little Canada, MN US

Patent application numberDescriptionPublished
20110279477Medical Image Processing and Handling System - An image processing and handling system is provided for the efficient combination of image data from multiple sources and of different types. The system includes an image processing device having an electronic control unit (ECU) that receives a first set of image data from an image data provider such as a PACS server over a telecommunications network. The first set of image data includes image pixel data from a first image of a physical structure in a living being and may be obtained from a DICOM compatible file. The ECU is further configured to combine the first set of image data with a second set of image data to form a combined set of image data. The second and combined sets of image data may each include pixel data for second and combined images, respectively of the physical structure. The ECU is further configured to transmit the combined set of image data to a remote computing device over a second telecommunications network11-17-2011

Samuel Herberg, Augusta, GA US

Patent application numberDescriptionPublished
20090209660BIOMATERIAL CONTAINING DEGRADATION STABILIZED POLYMER - The present invention relates to a polymer based material comprising a water binding agent, whereas the water binding agent is present in an amount sufficient to chemically and/or physically absorb and/or adsorb water to prevent degradation of the polymer. It also relates to a polymer based material which comprises a plasticizer or organic solvent as well as a multi-component material or composite including materials encompassing a second polymer and/or an active agent. Furthermore it relates to a method for manufacturing the polymer comprising material and use of the material for the preparation of a pharmaceutical composition to be used for treatment of bone, cartilage and/or periodontal defects. The invention also encompasses a kit using the polymeric material. Further, the present invention encompasses the use of a water binding agent for inhibiting water induced degradation of a polymer comprising material, for inducing blood clot stabilization in a polymer comprising material and for increasing storage stability in a polymer comprising material, wherein the water binding agent is not removed prior to application of the material.08-20-2009

Wolfgang E. Herberg, Eversen DE

Patent application numberDescriptionPublished
20120018173WELLBORE TOOL WITH EXHANGABLE BLADES - A method for conducting a wellbore operation includes disconnecting a radially projecting member from a first sub without uncoupling a second sub from the first sub. The method may include also coupling the first sub to the second sub with a connector that includes an electrical connection. An associated apparatus may include a sub having at least one conductor connected to a connector; and at least one radially projecting member removably coupled to the sub.01-26-2012

Wolfgang Eduard Herberg, Bergen DE

Patent application numberDescriptionPublished
20100139981Hole Enlargement Drilling Device and Methods for Using Same - A bottomhole assembly (BHA) coupled to a drill string includes one or more controllers, and a hole enlargement device that selectively enlarges the diameter of the wellbore formed by the drill bit. The hole enlargement device includes an actuation unit that may move extendable cutting elements o the hole enlargement device between a radially extended position and a radially retracted position. The actuation unit may be responsive to a signal that is transmitted from a downhole and/or a surface location. The hole enlargement device may also include one or more position sensors that transmit a position signal indicative of a radial position of the cutting elements. In an illustrative operating mode, one or more operating parameters of the hole enlargement device may be adjusted based on one or more measured parameters. This adjustment may be done in a closed-loop or automated fashion and/or by human personnel.06-10-2010